In clinical research, patient variability manifests in several forms
Adverse Reactions in a Clinical Trial of Pediatric Patients Aged 12 Years and Older with Obesity WEGOVY was evaluated in a 68-week, double-blind, randomized, parallel group, placebo-controlled, multi-center trial in 201 pediatric patients aged 12 years and older with obesity [see Clinical Studies (14.3)]
By targeting receptors in the brain that control hunger cues, Wegovy can help patients feel fuller with less food and stay satiated longer, reducing overall intake
What side effects are common with GLP-1 medication
If you are still choosing where to start, our local guide to how to find and vet a supervised semaglutide provider near you in Miami and what to expect pairs well with this one